IKEGAMI Yoji 池上洋二

Researcher Number	50322524
Other IDs
Affiliation (based on the past Project Information) *help	2005 – 2006: 明治薬科大学, 薬学部, 講師
Review Section/Research Field	Principal Investigator Medical pharmacy
Keywords	Principal Investigator Drug resistance / Cancer / Pharmacy / 薬剤耐性 / 癌 / 薬学

Research Projects
(1 results)
Research Products
(8 results)

Drug Resistance which ABCG2/BCRP contributesPrincipal Investigator
- Principal Investigator
  
  IKEGAMI Yoji
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Meiji Pharmaceutical University

All 2007 2006 2005

All Journal Article

[Journal Article] Re-evaluation and functional classification of nonsynonymous single nucleotide polymorphisms of human ABC transporter ABCG2.2007
- Author(s)
  Tamura A., Wakabayashi K., Onishi Y., Takeda M., Ikegami Y., Sawada S., Tsuji M., Matsuda Y., Ishikawa T.
- Journal Title
  
  Cancer Sci. 98(2)
  
  Pages: 231-239
- Data Source
  KAKENHI-PROJECT-17590139
[Journal Article] Re-evaluation and functional classification of nonsynonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.2007
- Author(s)
  Tamura A., Wakabayashi K., Onishi Y., Takeda M., Ikegami Y., Sawada S., Tsuji M., Matsuda Y., Ishikawa T.
- Journal Title
  
  Cancer Sci. 98
  
  Pages: 231-239
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590139
[Journal Article] Transport mechanism-based drug molecular design : Novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.2006
- Author(s)
  Ishikawa T., Ikegami Y., Sano K., Nakagawa H., Sawada S.
- Journal Title
  
  Curr.Pharm.Des. 12(3)
  
  Pages: 313-325
- Data Source
  KAKENHI-PROJECT-17590139
[Journal Article] Transport mechanism-based drug molecular design : Novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.2006
- Author(s)
  Ishikawa T., Ikegami Y., Sano K., Nakagawa H., Sawada S.
- Journal Title
  
  Curr Pharm Des. 12
  
  Pages: 313-325
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590139
[Journal Article] Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer.2006
- Author(s)
  Nakagawa H., Saito H., Ikegami Y., Aida-Hyugaji S., Sawada S., Ishikawa T.
- Journal Title
  
  Cancer Lett. 234
  
  Pages: 81-89
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590139
[Journal Article] Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer.2006
- Author(s)
  Nakagawa H., Saito H., Ikegami Y., Aida-Hyugaji S., Sawada S., Ishikawa T.
- Journal Title
  
  Cancer Lett. 234(1)
  
  Pages: 81-89
- Data Source
  KAKENHI-PROJECT-17590139
[Journal Article] Gefitinib("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.2005
- Author(s)
  Nakamura Y., Oka M., Soda H., Shiozawa K., Yoshikawa M., Itoh A., Ikegami Y., Tsurutani J., Nakatomi K., Kitazaki T., Doi S., Yoshida H., Kohno S.
- Journal Title
  
  Cancer Res. 65
  
  Pages: 1541-1546
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17590139
[Journal Article] Gefitinib("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.2005
- Author(s)
  Nakamura Y, Oka M., Soda H., Shiozawa K., Yoshikawa M., Itoh A., Ikegami Y., Tsurutani J., Nakatomi K., Kitazaki T., Doi S., Yoshida H., Kohno S.
- Journal Title
  
  Cancer Res. 65
  
  Pages: 1541-1546
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17590139

IKEGAMI Yoji 池上 洋二

Research Projects

Research Products

Drug Resistance which ABCG2/BCRP contributesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Re-evaluation and functional classification of nonsynonymous single nucleotide polymorphisms of human ABC transporter ABCG2.2007

Author(s)

Journal Title

Data Source

[Journal Article] Re-evaluation and functional classification of nonsynonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.2007

Author(s)

Journal Title

Description

Data Source

[Journal Article] Transport mechanism-based drug molecular design : Novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.2006

Author(s)

Journal Title

Data Source

[Journal Article] Transport mechanism-based drug molecular design : Novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer.2006

Author(s)

Journal Title

Description

Data Source

[Journal Article] Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer.2006

Author(s)

Journal Title

Data Source

[Journal Article] Gefitinib("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Gefitinib("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.2005

Author(s)

Journal Title

Description

Data Source

IKEGAMI Yoji 池上洋二